Adalimumab-Induced Acute Myeloid Leukaemia In A Patient With Crohn'S Disease
BMJ CASE REPORTS(2019)
摘要
We present a patient with Crohn's disease under treatment with adalimumab who developed acute myeloid leukaemia (AML) with core-binding factor beta gene rearrangement. This case report emphasises the importance of long-term close follow-up of patients receiving adalimumab because of the increased risk of developing AML and other malignancies.
更多查看译文
关键词
haematology (drugs and medicines), crohn's disease
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要